Developing Antitussive Alternatives To DXM Would Offset Commercial Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
Development of new OTC antitussives is an immature area of study and a major unmet medical need that could help protect manufacturers from lost sales if dextromethorphan is no longer available OTC in the future.